These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 38632255)

  • 1. The prognostic value of sialylation-related long non-coding RNAs in lung adenocarcinoma.
    Wang B; Hou C; Yu X; Liu J; Wang J
    Sci Rep; 2024 Apr; 14(1):8879. PubMed ID: 38632255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of sialylation-related long noncoding RNAs to develop a novel signature for predicting prognosis, immune landscape, and chemotherapy response in colorectal cancer.
    Zhou M; Lv S; Hou Y; Zhang R; Wang W; Yan Z; Li T; Gan W; Zeng Z; Zhang F; Yang M
    Front Immunol; 2022; 13():994874. PubMed ID: 36330513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization and validation of a ferroptosis-related LncRNA signature as a novel prognostic model for lung adenocarcinoma in tumor microenvironment.
    Wang Y; Lu G; Xue X; Xie M; Wang Z; Ma Z; Feng Y; Shao C; Duan H; Pan M; Ding P; Li X; Han J; Yan X
    Front Immunol; 2022; 13():903758. PubMed ID: 36016939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Value and Immune Landscapes of Four Types of RNA Modification Writer-Related LncRNAs Signature in Lung Adenocarcinoma.
    Qian Y; Zhang Q; Ren Y; Cao L; Zheng S; Li B; Wu X; Meng Z; Xu K
    J Cancer; 2024; 15(15):4818-4837. PubMed ID: 39132150
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification Invasion-Related Long Non-Coding RNAs in Lung Adenocarcinoma and Analysis of Competitive Endogenous RNA Regulatory Networks.
    Mao Y; Cai F; Jiang T; Zhu X
    Int J Gen Med; 2023; 16():1817-1831. PubMed ID: 37213476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Two Subtypes and Prognostic Characteristics of Lung Adenocarcinoma Based on Pentose Phosphate Metabolic Pathway-Related Long Non-coding RNAs.
    Liu C; Wang Y
    Front Public Health; 2022; 10():902445. PubMed ID: 35801241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cuproptosis-related long non-coding RNA signature to predict the prognosis and immune microenvironment characterization for lung adenocarcinoma.
    Ma S; Zhu J; Wang M; Zhu J; Wang W; Xiong Y; Jiang R; Seetharamu N; Abrão FC; Puthamohan VM; Liu L; Jiang T
    Transl Lung Cancer Res; 2022 Oct; 11(10):2079-2093. PubMed ID: 36386454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of RNA Methylation Modification-immune-related lncRNA Molecular Subtypes and Prognostic Scoring System in Lung Adenocarcinoma.
    Wang J; Shu J
    Curr Med Chem; 2024; 31(12):1539-1560. PubMed ID: 37680151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction and validation of an angiogenesis-related lncRNA prognostic model in lung adenocarcinoma.
    Gong Q; Huang X; Chen X; Zhang L; Zhou C; Li S; Song T; Zhuang L
    Front Genet; 2023; 14():1083593. PubMed ID: 36999053
    [No Abstract]   [Full Text] [Related]  

  • 10. Relationships of N6-Methyladenosine-Related Long Non-Coding RNAs With Tumor Immune Microenvironment and Clinical Prognosis in Lung Adenocarcinoma.
    Zhao J; Lin X; Zhuang J; He F
    Front Genet; 2021; 12():714697. PubMed ID: 34777460
    [No Abstract]   [Full Text] [Related]  

  • 11. A disulfidptosis-related lncRNA signature for predicting prognosis and evaluating the tumor immune microenvironment of lung adenocarcinoma.
    Song Z; Cao X; Wang X; Li Y; Zhang W; Wang Y; Chen L
    Sci Rep; 2024 Feb; 14(1):4621. PubMed ID: 38409243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cuproptosis-related lncRNA signature for predicting prognosis and immunotherapy response of lung adenocarcinoma.
    Yu S; Tang L; Zhang Q; Li W; Yao S; Cai Y; Cheng H
    Hereditas; 2023 Jul; 160(1):31. PubMed ID: 37482612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the three subtypes and the prognostic characteristics of stomach adenocarcinoma: analysis of the hypoxia-related long non-coding RNAs.
    Fan Z; Wang Y; Niu R
    Funct Integr Genomics; 2022 Oct; 22(5):919-936. PubMed ID: 35665866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sialylation-associated long non-coding RNA signature predicts the prognosis, tumor microenvironment, and immunotherapy and chemotherapy options in uterine corpus endometrial carcinoma.
    Chen J; Wu T; Yang Y
    Cancer Cell Int; 2024 Sep; 24(1):314. PubMed ID: 39261877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic signature of lipid metabolism associated LncRNAs predict prognosis and treatment of lung adenocarcinoma.
    Zhao J; Li G; Zhao G; Wang W; Shen Z; Yang Y; Huang Y; Ye L
    Front Oncol; 2022; 12():986367. PubMed ID: 36387240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive assessment of base excision repair (BER)-related lncRNAs as prognostic and functional biomarkers in lung adenocarcinoma: implications for personalized therapeutics and immunomodulation.
    Zhang J; Song L; Li G; Liang A; Cai X; Huang Y; Zhu X; Zhou X
    J Cancer Res Clin Oncol; 2023 Dec; 149(19):17199-17213. PubMed ID: 37789154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. m6A-related lncRNA-based immune infiltration characteristic analysis and prognostic model for colonic adenocarcinoma.
    Wang HL; Ye ZM; He ZY; Huang L; Liu ZH
    Hereditas; 2023 Feb; 160(1):6. PubMed ID: 36755298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel endoplasmic reticulum stress-related lncRNA signature for prognosis prediction and immune response evaluation in Stomach adenocarcinoma.
    Song Z; Su M; Li X; Xie J; Han F; Yao J
    BMC Gastroenterol; 2023 Dec; 23(1):432. PubMed ID: 38066437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value and immune landscapes of immunogenic cell death-associated lncRNAs in lung adenocarcinoma.
    Shu K; Cai C; Chen W; Ding J; Guo Z; Wei Y; Zhang W
    Sci Rep; 2023 Nov; 13(1):19151. PubMed ID: 37932413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer.
    Wang Y; Zhu GQ; Tian D; Zhou CW; Li N; Feng Y; Zeng MS
    BMC Cancer; 2022 Mar; 22(1):316. PubMed ID: 35331183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.